248 related articles for article (PubMed ID: 23765843)
1. Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice.
Shukla S; Bhaskaran N; Maclennan GT; Gupta S
Prostate; 2013 Oct; 73(14):1507-17. PubMed ID: 23765843
[TBL] [Abstract][Full Text] [Related]
2. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of FOXO3A during prostate cancer progression.
Shukla S; Shukla M; Maclennan GT; Fu P; Gupta S
Int J Oncol; 2009 Jun; 34(6):1613-20. PubMed ID: 19424579
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
[TBL] [Abstract][Full Text] [Related]
5. IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.
Chapuis N; Park S; Leotoing L; Tamburini J; Verdier F; Bardet V; Green AS; Willems L; Agou F; Ifrah N; Dreyfus F; Bismuth G; Baud V; Lacombe C; Mayeux P; Bouscary D
Blood; 2010 Nov; 116(20):4240-50. PubMed ID: 20671123
[TBL] [Abstract][Full Text] [Related]
6. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
Guigon CJ; Zhao L; Willingham MC; Cheng SY
Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
[TBL] [Abstract][Full Text] [Related]
7. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
Fang L; Wang H; Zhou L; Yu D
Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells.
Tabassam FH; Graham DY; Yamaoka Y
Helicobacter; 2012 Jun; 17(3):193-202. PubMed ID: 22515357
[TBL] [Abstract][Full Text] [Related]
9. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
Boreddy SR; Pramanik KC; Srivastava SK
Clin Cancer Res; 2011 Apr; 17(7):1784-95. PubMed ID: 21350002
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells.
Li Q; Huang H; He Z; Sun Y; Tang Y; Shang X; Wang C
Sci China Life Sci; 2018 May; 61(5):550-558. PubMed ID: 29119376
[TBL] [Abstract][Full Text] [Related]
12. Analysis of complex protein kinase B signalling pathways in human prostate cancer samples.
Jendrossek V; Henkel M; Hennenlotter J; Vogel U; Ganswindt U; Müller I; Handrick R; Anastasiadis AG; Kuczyk M; Stenzl A; Belka C
BJU Int; 2008 Aug; 102(3):371-82. PubMed ID: 18476967
[TBL] [Abstract][Full Text] [Related]
13. PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis.
Cao J; Zhu S; Zhou W; Li J; Liu C; Xuan H; Yan J; Zheng L; Zhou L; Yu J; Chen G; Huang Y; Yu Z; Feng L
PLoS One; 2013; 8(12):e77922. PubMed ID: 24339862
[TBL] [Abstract][Full Text] [Related]
14. FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma.
Santo EE; Stroeken P; Sluis PV; Koster J; Versteeg R; Westerhout EM
Cancer Res; 2013 Apr; 73(7):2189-98. PubMed ID: 23378341
[TBL] [Abstract][Full Text] [Related]
15. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
[TBL] [Abstract][Full Text] [Related]
16. PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells.
Luo H; Yang Y; Duan J; Wu P; Jiang Q; Xu C
Cell Death Dis; 2013 Feb; 4(2):e481. PubMed ID: 23392169
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH
J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.
Saxena A; Tammali R; Ramana KV; Srivastava SK
Antioxid Redox Signal; 2013 Apr; 18(11):1249-62. PubMed ID: 22978663
[TBL] [Abstract][Full Text] [Related]
19. Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling.
Zhang Z; Zhang T; Zhou Y; Wei X; Zhu J; Zhang J; Wang C
Cell Physiol Biochem; 2015; 35(4):1643-53. PubMed ID: 25824462
[TBL] [Abstract][Full Text] [Related]
20. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.
Lynch RL; Konicek BW; McNulty AM; Hanna KR; Lewis JE; Neubauer BL; Graff JR
Mol Cancer Res; 2005 Mar; 3(3):163-9. PubMed ID: 15798096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
